CIK 0001583771
- Non-accelerated filer
- Smaller reporting company
Hepion Pharmaceuticals, Inc.
Sign in to watch- Tickers
- HEPA CTRVP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462783806
- Phone
- +1 732-902-4000
- Business address
- 34 SHREWSBURY AVE., SUITE 1D, RED BANK, NJ, 07701
- Former names
- ContraVir Pharmaceuticals, Inc.
Securities
- HEPA Common stock OTC
- CTRVP Common stock OTC
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 500,000 shares at $0.05 ($25,000)
- 4 Open-market buy Interim CEO bought 2,000,000 shares at $0.05 ($100,000)
- 4 Open-market buy Director bought 2,000,000 shares at $0.05 ($100,000)
- 4 Open-market buy Chief Operating Officer bought 2,000,000 shares at $0.05 ($100,000)
- 4 Open-market buy Executive Chairman bought 10,000,000 shares at $0.05 ($500,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,250,000 shares at $0.04 ($50,000)
- 4 Open-market buy Executive Chairman bought 6,250,000 shares at $0.04 ($250,000)
- 4 Open-market buy Director bought 1,250,000 shares at $0.04 ($50,000)
- 4 Open-market buy Interim CEO bought 1,250,000 shares at $0.04 ($50,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 2 of 8 · 158 filings